Clinical trial
Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis
NCT00469703 · Winthrop University Hospital, Other · Terminated
Key facts
| NCT number | NCT00469703 |
|---|---|
| Title | Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis |
| Official title | A Phase II, Open-Label, Single Center Pilot Study to Determine the Safety and Efficacy of THALOMID (Thalidomide) in Patients With Chronic Pancreatitis. |
| Lead sponsor | Winthrop University Hospital, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Pancreatitis |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 10 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 4, 2007 |
| Last update posted | Jan 16, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: